
Year
DEALS // DEV.
Country
Therapeutic Area
Study Phase
Deal Type
Product Type
Dosage Form
Lead Product
Target

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
Lead Product(s) : Arthrospira maxima
Therapeutic Area : Otolaryngology (Ear, Nose, Throat)
Study Phase : Undisclosed
Sponsor : Undisclosed
Deal Size : Inapplicable
Deal Type : Inapplicable
Inner Ear Support' Oral Capsule in Patients with Sudden Sensorineural Hearing Loss
Details : Arthrospira maxima is a Plant Extract/Herbal drug candidate, which is currently being evaluated in clinical studies for the treatment of Hearing Loss, Sensorineural.
Product Name : Undisclosed
Product Type : Plant Extract/Herbal
Upfront Cash : Inapplicable
May 30, 2025
Lead Product(s) : Arthrospira maxima
Therapeutic Area : Otolaryngology (Ear, Nose, Throat)
Highest Development Status : Undisclosed
Sponsor : Undisclosed
Deal Size : Inapplicable
Deal Type : Inapplicable

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
Lead Product(s) : Multicomponent Dietary Supplement
Therapeutic Area : Ophthalmology
Study Phase : Undisclosed
Sponsor : Shih Chien Huang
Deal Size : Inapplicable
Deal Type : Inapplicable
Dietary Supplementation on Tear Secretion and Inflammation in DES
Details : Multicomponent Dietary Supplement is a Dietary Supplement drug candidate, which is currently being evaluated in clinical studies for the treatment of Dry Eye Syndromes.
Product Name : Undisclosed
Product Type : Dietary Supplement
Upfront Cash : Inapplicable
December 17, 2024
Lead Product(s) : Multicomponent Dietary Supplement
Therapeutic Area : Ophthalmology
Highest Development Status : Undisclosed
Sponsor : Shih Chien Huang
Deal Size : Inapplicable
Deal Type : Inapplicable

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
Lead Product(s) : FB-1603
Therapeutic Area : Oncology
Study Phase : Phase I/ Phase II
Sponsor : National Taiwan University Hospital
Deal Size : Inapplicable
Deal Type : Inapplicable
Details : FB-1603 is a drug candidate, which is currently being evaluated in phase I/ phase II clinical studies for the treatment of Carcinoma, Hepatocellular.
Product Name : Undisclosed
Product Type : Undisclosed
Upfront Cash : Inapplicable
June 27, 2024
Lead Product(s) : FB-1603
Therapeutic Area : Oncology
Highest Development Status : Phase I/ Phase II
Sponsor : National Taiwan University Hospital
Deal Size : Inapplicable
Deal Type : Inapplicable

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
Lead Product(s) : Spirulina
Therapeutic Area : Infections and Infectious Diseases
Study Phase : Undisclosed
Recipient : Taipei Medical University WanFang Hospital
Deal Size : Inapplicable
Deal Type : Inapplicable
Spirulina (FEM-102) Supplement to Chronic Hepatitis B Patients
Details : Spirulina is a Plant Extract/Herbal drug candidate, which is currently being evaluated in clinical studies for the treatment of Hepatitis B, Chronic.
Product Name : Undisclosed
Product Type : Plant Extract/Herbal
Upfront Cash : Inapplicable
January 22, 2021
Lead Product(s) : Spirulina
Therapeutic Area : Infections and Infectious Diseases
Highest Development Status : Undisclosed
Recipient : Taipei Medical University WanFang Hospital
Deal Size : Inapplicable
Deal Type : Inapplicable

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
Lead Product(s) : Apomivir
Therapeutic Area : Infections and Infectious Diseases
Study Phase : Phase II
Sponsor : Undisclosed
Deal Size : Inapplicable
Deal Type : Inapplicable
Study to Investigate the Efficacy and Safety of Apomivir®
Details : Apomivir is a Other Small Molecule drug candidate, which is currently being evaluated in phase II clinical studies for the treatment of Influenza, Human.
Product Name : Undisclosed
Product Type : Miscellaneous
Upfront Cash : Inapplicable
September 03, 2012
Lead Product(s) : Apomivir
Therapeutic Area : Infections and Infectious Diseases
Highest Development Status : Phase II
Sponsor : Undisclosed
Deal Size : Inapplicable
Deal Type : Inapplicable
